U.S. Department of Health and Human Services
​​

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

Cystic Fibrosis Research and Translation Centers

The NIDDK-supported Cystic Fibrosis Research and Translation Centers are part of an integrated program of research support designed to enhance multidisciplinary research in pathogenesis and treatment of cystic fibrosis.  Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions or a group of institutions with an established, comprehensive research base in cystic fibrosis.  The goal of these CF Research and Translation Centers is to support research to develop and test therapies for CF.  These Centers provide resources for communication and collaboration between basic and clinical researchers to study the multiple organ systems affect by CF.​​​​​​​​​​
​​​​​​​​​​​
 

 NIDDK Staff

 
Thomas Eggerman, M.D., Ph.D.Cystic fibrosis research and translation centers, clinical trials, and islet transplantation

Funding Mechanisms

NIDDK funds Cystic Fibrosis Centers under the P30 funding mechanism

 

Center Sites 

  • Case Western Reserve
  • University of Alabama at Birmingham
  • University of California San Francisco
  • University of Pittsburgh
  • University of Washington
​​​

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
10/20/2014Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) (Summary) RFA-DK-14-023
9/24/2014Nuclear Organization and Function Interdisciplinary Consortium (NOFIC)(U54) (Summary) RFA-RM-14-006
9/24/2014Psychosocial and Behavioral Aspects of Bariatric Surgery (R01) (Summary) RFA-DK-14-026
9/4/2014Advancing Interventions to Improve Medication Adherence (R01) (Summary) PA-14-334
8/25/2014Identification of Novel Targets and Pathways Mediating Weight Loss, Diabetes Resolution and Related Metabolic Disease after Bariatric Surgery in Humans (R01) (Summary) RFA-DK-14-025
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of dkNET is to develop a community-based network for…

NIDDK Repository for Biosamples and Data

Supports Data, Biosample, and Genetic Repositories to increase the impact of current and previously funded NIDDK studies by making their data and biospecimens available to the broader scientific community. These Repositories enable scientists not…

Epidemiology of Diabetes Interventions and Complications

An observational study examining the risk factors associated with the long-term complications of type 1 diabetes. The study began in 1994 and follows the 1441 participants previously enrolled in the Diabetes Control and Complications Trial (DCCT).

View Additional Research Resources

 

 NIDDK Active Trials in Cystic Fibrosis

 
​View related clinical trials from ClinicalTrials.gov​.

 

 Related Study Sections

 
​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections​ from the NIH's Center for Scientific Review.